Paliperidone Tablet, Extended Release
Product Images NDC 43975-350

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 43975-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Paliperidone Extended-release Tablets 1.5 mg oral tablets packaging label showing key information including the dosage strength, quantity of 30 tablets, and instructions that tablets should be swallowed whole without dividing or crushing. The label lists manufacturer Inventia Healthcare Limited in India and distributor ANI Pharmaceuticals, Inc. in Minnesota, USA. Additional storage instructions and barcode are also visible.*

FDA Label Image

Image 02

Paliperidone extended-release tablets 3 mg, oral dosage form, packaged as 30 tablets by ANI Pharmaceuticals, Inc. The label includes dosage instructions to swallow whole without dividing, crushing, or chewing. It states storage at controlled room temperature and includes manufacturer and distributor details, a barcode, and a serialized GTIN and lot information.*

FDA Label Image

Image 03

Paliperidone extended-release tablets 6 mg label from ANI Pharmaceuticals, Inc. The label states the tablets should be swallowed whole and not divided, crushed or chewed. The package contains 30 tablets and includes storage instructions at controlled room temperature, manufacturer and distributor information, and a barcode with GTIN, lot, expiration, and serial numbers.*

FDA Label Image

Image 04

Paliperidone 9 mg extended-release tablets packaging label by ANI Pharmaceuticals, Inc. The label indicates 30 tablets per container, prescription use only, and instructs tablets to be swallowed whole without dividing, crushing, or chewing. Additional details include storage instructions, manufacturer information, and barcodes.*

FDA Label Image

Image 05

Chemical structure of paliperidone, an active ingredient in oral extended-release tablets. The molecule features multiple ring systems, including a fluorinated aromatic ring and nitrogen-containing heterocycles, consistent with paliperidone's pharmacological profile.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.